Literature DB >> 31951494

Reply to D.M. Green.

David B Dix1, Conrad V Fernandez1, Yueh-Yun Chi1, Lindsay A Renfro1, Jeffrey S Dome Md1.   

Abstract

Mesh：

Year:  2020        PMID： 31951494      PMCID： PMC7048164          DOI： 10.1200/JCO.19.03113

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

Authors:  David B Dix; Nita L Seibel; Yueh-Yun Chi; Geetika Khanna; Eric Gratias; James R Anderson; Elizabeth A Mullen; James I Geller; John A Kalapurakal; Arnold C Paulino; Elizabeth J Perlman; Peter F Ehrlich; Marcio Malogolowkin; Julie M Gastier-Foster; Elizabeth Wagner; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2018-04-16       Impact factor: 44.544

2.  The value of surgery in directing therapy for patients with Wilms' tumor with pulmonary disease. A report from the National Wilms' Tumor Study Group (National Wilms' Tumor Study 5).

Authors:  Peter F Ehrlich; Thomas E Hamilton; Paul Grundy; Michael Ritchey; Gerald Haase; Robert C Shamberger
Journal:  J Pediatr Surg       Date:  2006-01       Impact factor: 2.545

3.  Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group.

Authors:  Paul E Grundy; Daniel M Green; Astrid C Dirks; Andrea E Berendt; Norman E Breslow; James R Anderson; Jeffrey S Dome
Journal:  Pediatr Blood Cancer       Date:  2012-03-15       Impact factor: 3.167

4.  Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor: A Children's Oncology Group AREN0532 and AREN0533 Study Report.

Authors:  David B Dix; Conrad V Fernandez; Yueh-Yun Chi; Elizabeth A Mullen; James I Geller; Eric J Gratias; Geetika Khanna; John A Kalapurakal; Elizabeth J Perlman; Nita L Seibel; Peter F Ehrlich; Marcio Malogolowkin; James Anderson; Julie Gastier-Foster; Robert C Shamberger; Yeonil Kim; Paul E Grundy; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2019-08-26       Impact factor: 44.544

5.  The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study.

Authors:  Anne M J B Smets; Harm van Tinteren; Christophe Bergeron; Beatriz De Camargo; Norbert Graf; Kathy Pritchard-Jones; Jan de Kraker
Journal:  Eur J Cancer       Date:  2011-06-22       Impact factor: 9.162

6.  Erratum.

Authors: 
Journal:  J Clin Oncol       Date:  2019-10-10       Impact factor: 44.544

7.  Augmentation of Therapy for Combined Loss of Heterozygosity 1p and 16q in Favorable Histology Wilms Tumor.

Authors:  Daniel M Green
Journal:  J Clin Oncol       Date:  2020-01-17       Impact factor: 44.544

8.  Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.

Authors:  Paul E Grundy; Norman E Breslow; Sierra Li; Elizabeth Perlman; J Bruce Beckwith; Michael L Ritchey; Robert C Shamberger; Gerald M Haase; Giulio J D'Angio; Milton Donaldson; Max J Coppes; Marcio Malogolowkin; Patricia Shearer; Patrick R M Thomas; Roger Macklis; Gail Tomlinson; Vicki Huff; Daniel M Green
Journal:  J Clin Oncol       Date:  2005-08-29       Impact factor: 44.544
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.